KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Bunge Global (BG) Asset Writedowns and Impairment (2023 - 2024)

Bunge Global's Asset Writedowns and Impairment history spans 2 years, with the latest figure at $5.0 million for Q4 2024.

For Q4 2024, Asset Writedowns and Impairment fell 89.58% year-over-year to $5.0 million; the TTM value through Dec 2024 reached $114.0 million, changed N/A, while the annual FY2025 figure was $53.0 million, 29.27% up from the prior year.
Asset Writedowns and Impairment reached $5.0 million in Q4 2024 per BG's latest filing, down from $27.0 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $48.0 million in Q4 2023 to a low of $5.0 million in Q4 2024.